Astrazeneca (AZN) Income towards Parent Company (2009 - 2026)
Astrazeneca (AZN) recorded Income towards Parent Company of $2.89 billion in Q2 2026, down 18.6% from $3.56 billion a year earlier and down 6.1% from the prior quarter.
Astrazeneca (AZN) Income towards Parent Company (2009 - 2026) Analysis & Trends
On a TTM basis, Astrazeneca's Income towards Parent Company came in at $10.87 billion as of Jun 30, 2026, up 2.3% year-over-year; for FY2025, it was $12.92 billion, up 107.2% from FY2024.
- Annual Income towards Parent Company has a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
- Across earlier years, Income towards Parent Company came in at $6.24 billion in FY2024 (-6.8%), $6.69 billion in FY2023 (+177.2%), $2.41 billion in FY2022 and $112 million in FY2021 (-97.7%).
- Quarterly Income towards Parent Company has ranged from -$1.98 billion in Q3 2021 to $3.56 billion in Q2 2025 over the past five years.
- On a year-over-year basis, Income towards Parent Company rose in five of the last eight quarters, with growth averaging 35.6%.
- Peak year-over-year performance for Income towards Parent Company in the last five years was growth of 438.5% in Q1 2023, against a decline of 74.1% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.08 billion (Q1 2026), $2.33 billion (Q4 2025) and $2.58 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 2.33 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.45 Bn |
| Mar 31, 2025 | 2.92 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.93 Bn |
| Mar 31, 2024 | 2.18 Bn |
| Dec 31, 2023 | 960.00 Mn |
| Sep 30, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.80 Bn |
| Dec 31, 2022 | 901.00 Mn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 360.00 Mn |
| Mar 31, 2022 | 386.00 Mn |
| Dec 31, 2021 | -347.00 Mn |
| Sep 30, 2021 | -1.65 Bn |
Astrazeneca Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();